Cargando…
TRKB tyrosine kinase receptor is a potential therapeutic target for poorly differentiated oral squamous cell carcinoma
It has been reported that one of the neurotrophin receptors, tropomyosin receptor kinase B (TRKB), is frequently overexpressed in various tumor tissues including oral squamous cell carcinoma (OSCC), and that its upregulation promotes tumor progression in human cancers. However, the correlation betwe...
Autores principales: | Moriwaki, Kazumasa, Ayani, Yusuke, Kuwabara, Hiroko, Terada, Tetsuya, Kawata, Ryo, Asahi, Michio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5982746/ https://www.ncbi.nlm.nih.gov/pubmed/29861866 http://dx.doi.org/10.18632/oncotarget.25396 |
Ejemplares similares
-
BDNF/TRKB axis provokes EMT progression to induce cell aggressiveness via crosstalk with cancer-associated fibroblasts in human parotid gland cancer
por: Moriwaki, Kazumasa, et al.
Publicado: (2022) -
Augmented O‐GlcNAcylation of AMP‐activated kinase promotes the proliferation of LoVo cells, a colon cancer cell line
por: Ishimura, Emi, et al.
Publicado: (2017) -
Hemorrhage of MRI and Immunohistochemical Panels Distinguish Secretory Carcinoma From Acinic Cell Carcinoma
por: Kuwabara, Hiroko, et al.
Publicado: (2018) -
Management and outcome of parotid mucoepidermoid carcinoma by histological grade: A 21‐year review
por: Taniuchi, Masataka, et al.
Publicado: (2022) -
Regulation of TrkB receptor tyrosine kinase and its internalization by neuronal activity and Ca(2+) influx
por: Du, Jing, et al.
Publicado: (2003)